Hyperplasia of mammary glands
Conditions
Interventions
pre-acupuncture intervention Group:Acupuncture treatment
Oral drug RuPiXiao control group:Take Oral drug RupiXiao
Sponsors
The First Affiliated Hospital of Yunnan University of Chinese Medicine /Yunnan Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Those who meet the diagnostic criteria of mammary gland hyperplasia and in line with TCM syndrome differentiation and classification. 2. Women aged 18 to 55 years whom with Normal menstrual cycle (Definition of Normal menstrual cycle 28±7days). 3. Those who sign the informed consent form, are voluntary subjects, have good compliance, and are able to complete the treatment course. 4. Those who have not received other drug treatment or other relevant intervention measures for breast hyperplasia within 6 months.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women; 2. Those who with a clear family history of breast cancer; 3. Those who with malignant breast tumors; 4. Those who with cardiovascular and cerebrovascular diseases, hepatic and renal insufficiency, hematopoietic diseases and endocrine diseases; 5. Those who with mental disorders and unable to cooperate with the treatment research plan; 6. Those who are participating in other clinical trials. PS:Subjects who meet any of the above exclusion criteria shall be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| E2;P;PRL;T;LH;FSH;Breast ultrasound;CA15-3; | — |
Secondary
| Measure | Time frame |
|---|---|
| Breast pain grade;Breast lumps size grading;score of Scope of breast lumps;Breast lumps hardness grade;Body concomitant symptom score; | — |
Countries
China
Contacts
Public ContactRong Zhao
The First Affiliated Hospital of Yunnan University of Chinese Medicine/YunNan Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed